Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Tourmaline Bio, Inc. (TRML)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
29 Jan 2024
MCDADE MARK
Director
Tourmaline Bio, Inc.
(TRML)
448,431
+28%
100,000
$32.50
$3,250,000.00
BUY
25 Oct 2023
Castelein Caley
Director
Tourmaline Bio, Inc.
(TRML)
516,519
+4%
20,000
$14.03
$280,584.00
BUY
24 Oct 2023
Thiara Parvinder
Director
Tourmaline Bio, Inc.
(TRML)
82,782
+9%
7,000
$11.08
$77,540.00
BUY
24 Oct 2023
KANTOFF AARON
Director
Tourmaline Bio, Inc.
(TRML)
45,391
+19%
7,500
$11.86
$88,950.00
BUY
24 Oct 2023
Kulkarni Sandeep Chidambar
CEO, Director, Officer
Tourmaline Bio, Inc.
(TRML)
725,735
+1%
9,650
$11.49
$110,912.00
SELL
12 Jun 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,771,392
-1%
44,020
$2.55
$112,307.44
SELL
7 Jun 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,815,412
-3%
141,062
$2.43
$342,504.25
SELL
5 Jun 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
2,756,474
-1%
33,390
$2.53
$84,350.16
SELL
1 Jun 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
2,789,864
-1%
31,531
$2.53
$79,792.75
SELL
21 Apr 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
2,821,395
-0%
15,004
$2.35
$35,230.89
SELL
19 Apr 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
2,836,399
-2%
68,743
$2.27
$156,368.92
SELL
17 Apr 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
2,905,142
-4%
148,982
$2.14
$319,333.56
SELL
17 Mar 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,054,124
-0%
10,436
$2.06
$21,543.04
SELL
17 Mar 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,054,124
-0%
10,436
$2.06
$21,543.04
SELL
3 Mar 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,064,560
-0%
6,806
$2.06
$13,992.46
SELL
1 Mar 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,071,366
-0%
29
$2.05
$59.45
SELL
1 Mar 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,071,366
-0%
29
$2.05
$59.45
SELL
21 Feb 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,071,395
-0%
3,500
$2.05
$7,185.15
SELL
21 Feb 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,071,395
-0%
3,500
$2.05
$7,185.15
SELL
16 Feb 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,074,895
-0%
6,551
$2.05
$13,445.62
SELL
16 Feb 2023
Ildstad Suzanne
Director
Talaris Therapeutics, Inc.
(TALS)
3,074,895
-0%
6,551
$2.05
$13,445.62
SELL
22 Aug 2022
Ildstad Suzanne
Chief Scientific Officer, Officer
Talaris Therapeutics, Inc.
(TALS)
3,081,446
-14%
525,000
$2.80
$1,470,000.00
BUY
26 Jul 2022
Requadt Scott
Chief Executive Officer, Director, Officer
Talaris Therapeutics, Inc.
(TALS)
469,298
+1%
8,618
$4.24
$36,571.22
BUY
22 Jul 2022
Requadt Scott
Chief Executive Officer, Director, Officer
Talaris Therapeutics, Inc.
(TALS)
460,680
+2%
9,444
$3.75
$35,412.17
BUY
19 Jul 2022
Nader Francois
Director
Talaris Therapeutics, Inc.
(TALS)
138,500
+100%
138,500
$3.61
$500,020.00
BUY
19 Jul 2022
Nader Francois
Director
Talaris Therapeutics, Inc.
(TALS)
138,500
+100%
138,500
$3.61
$500,020.00
BUY
11 May 2021
Clarus Lifesciences III, L.P.
10% Owner
Talaris Therapeutics, Inc.
(TALS)
4,875,730
+0%
30,000
$17.00
$510,000.00
BUY
11 May 2021
Clarus Defined Exit I, L.P.
10% Owner
Talaris Therapeutics, Inc.
(TALS)
4,875,730
+0%
30,000
$17.00
$510,000.00
BUY
11 May 2021
Longitude Capital Partners III, LLC
10% Owner
Talaris Therapeutics, Inc.
(TALS)
3,220,775
+7%
235,000
$17.00
$3,995,000.00
BUY
11 May 2021
Agarwala Sandip
Director, 10% Owner
Talaris Therapeutics, Inc.
(TALS)
3,220,775
+7%
235,000
$17.00
$3,995,000.00
Home